Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 239

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease

Traish, Abdulmaged M., Saad, Farid, Feeley, Robert J., Guay, Andre · 2009 · Journal of Andrology

Abstract

A considerable body of evidence exists suggesting that androgen deficiency contributes to the onset, progression, or both of cardiovascular disease (CVD). The aim of this review is to evaluate the relationships between testosterone (T) deficiency and risk factors of CVD and to discuss the implications of androgen deficiency in men with cardiovascular risk factors. The relationship between androgen deficiency and endothelial function, lipid profiles, inflammatory responses, altered vascular smooth muscle reactivity, and hypertension are discussed with regard to CVD. A comprehensive literature search was carried out with the use of Pub Med from 1980 through 2009, and relevant articles pertinent to androgen deficiency and vascular disease were evaluated and discussed. Low T, whether attributed to hypogonadism or androgen deprivation therapy, in men with prostate carcinoma, produces adverse effects on cardiovascular health. Androgen deficiency is associated with increased levels of total cholesterol, low‐density lipoprotein, increased production of proinflammatory factors, and increased thickness of the arterial wall and contributes to endothelial dysfunction. Testosterone supplementation restores arterial vasoreactivity; reduces proinflammatory cytokines, total cholesterol, and triglyceride levels; and improves endothelial function but also might reduce high‐density lipoprotein levels. Testosterone is an anabolic hormone with a wide range of beneficial effects on men's health. The therapeutic role of T in men's health, however, remains a hotly debated issue for a number of reasons, including the purported risk of prostate cancer. In view of the emerging evidence suggesting that androgen deficiency is a risk factor for CVD, androgen replacement therapy could potentially reduce CVD risk in hypogonadal men. It should be emphasized, however, that androgen replacement therapy should be done with very thorough and careful monitoring for prostate diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2164/jandrol.108.007245

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Research works printed but not linked: 133

  1. 10.1111/j.1365-2362.2004.01339.x · DOI
  2. 10.1016/8756-3282(95)00441-6 · DOI
  3. 10.1001/archinte.167.12.1252 · DOI · Paper page
  4. 10.1210/jc.79.2.561 · DOI · Paper page
  5. 10.1016/j.jacc.2005.02.057 · doi:10.1016/j.jacc.2005.02.057
  6. 10.1161/01.CIR.78.3.539 · DOI · Paper page
  7. 10.1016/S0021-9150(02)00069-2 · DOI
  8. 10.2164/jandrol.108.005454 · DOI
  9. 10.1016/S0002-9343(01)00663-5 · DOI
  10. 10.1161/CIRCULATIONAHA.107.740365 · DOI
  11. 10.1002/cncr.21642 · DOI · Paper page
  12. 10.1091/mbc.10.10.3113 · DOI · Paper page
  13. 10.1007/s00210-007-0213-3 · DOI
  14. 10.2337/diab.47.2.290 · DOI
  15. 10.1681/ASN.2008060664 · DOI · Paper page
  16. 10.1111/j.1442-2042.2005.01145.x · DOI
  17. 10.1161/01.CIR.94.10.2614 · DOI · Paper page
  18. 10.1046/j.1440-1681.1999.03110.x · DOI
  19. 10.1038/sj.ijo.0802292 · DOI
  20. Dobrzycki S., 2003, An assessment of correlations between endogenous sex hormone levels and the extensiveness of coronary heart disease and the ejection fraction of the left ventricle in males, J Med Invest, 50, 162
  21. 10.1210/jc.86.3.1026 · DOI
  22. Dockery F., 2003, Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia, Clin Sci, 104, 195, 10.1042/cs1040195 · DOI · Paper page
  23. 10.1016/S0008-6363(01)00527-2 · DOI · Paper page
  24. 10.1080/13685530400004181 · DOI
  25. 10.1007/BF03344037 · DOI
  26. 10.1016/j.ceca.2006.09.003 · DOI
  27. 10.1038/sj.ijir.3901447 · DOI · Paper page
  28. 10.1016/j.amjcard.2005.07.005 · DOI
  29. 10.1210/jc.2006-0763 · DOI
  30. Foresta C., 2008, Androgens stimulate endothelial progenitor cells through an androgen‐mediated pathway, Clin Endo, 68, 284, 10.1111/j.1365-2265.2007.03036.x · DOI
  31. 10.1111/j.1745-7262.2008.00335.x · DOI
  32. 10.1016/0960-0760(94)90025-6 · DOI
  33. 10.2337/diacare.26.6.1869 · DOI
  34. 10.1152/ajpheart.2000.279.2.H610 · DOI
  35. 10.1161/01.ATV.19.8.1925 · DOI
  36. 10.1172/JCI10762 · DOI · Paper page
  37. 10.1053/meta.2001.24916 · DOI
  38. 10.2337/diab.43.2.212 · DOI · Paper page
  39. 10.1038/sj.ijo.0801279 · DOI · Paper page
  40. 10.1016/S0002-9149(00)00784-0 · DOI
  41. 10.1210/jc.77.6.1610 · DOI · Paper page
  42. 10.1080/13685530701653538 · DOI
  43. 10.1210/jcem.87.8.8762 · doi:10.1210/jcem.87.8.8762 · Paper page
  44. 10.1111/j.1464-410X.2008.07933.x · DOI
  45. 10.1210/en.2005-1243 · DOI
  46. 10.1253/circj.CJ-08-1102 · DOI · Paper page
  47. 10.1046/j.1365-2265.2001.01297.x · DOI
  48. 10.1097/01.fjc.0000175434.64412.9d · DOI
  49. Isidori AM, 2005, Androgens, cardiovascular disease and osteoporosis, J Endocrinol Invest, 28, 73
  50. 10.1111/j.1742-1241.2006.01112.x · DOI
  51. 10.1161/01.ATV.16.6.749 · DOI
  52. 10.1042/CS20030386 · DOI
  53. 10.1530/eje.0.1510029 · DOI
  54. 10.1210/jc.2002-021738 · DOI
  55. 10.2165/00129784-200505030-00001 · DOI
  56. 10.1038/ijir.2008.36 · DOI
  57. 10.1038/sj.bjp.0706936 · DOI
  58. 10.1046/j.1439-0272.2002.00468.x · doi:10.1046/j.1439-0272.2002.00468.x
  59. 10.1093/oxfordjournals.aje.a114704 · DOI
  60. 10.1074/jbc.M200491200 · DOI · Paper page
  61. 10.1016/j.steroids.2004.02.004 · DOI
  62. 10.1210/er.2003-0005 · DOI · Paper page
  63. 10.1111/j.1745-7262.2007.00327.x · DOI
  64. 10.1001/jama.300.2.173 · DOI · Paper page
  65. Ly LP, 2001, A double‐blind, placebo‐controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency, J Clin Endocrinol Metab, 86, 4078, 10.1210/jcem.86.9.7821 · doi:10.1210/jcem.86.9.7821 · Paper page
  66. 10.1001/archinte.167.20.2249 · DOI · Paper page
  67. 10.1097/01.ju.0000169490.78443.59 · DOI · Paper page
  68. 10.1016/j.jacc.2005.01.052 · DOI · Paper page
  69. 10.1016/j.atherosclerosis.2007.05.009 · DOI
  70. 10.1016/j.amjcard.2003.07.044 · DOI
  71. 10.1677/joe.0.1780373 · DOI · Paper page
  72. 10.1093/qjmed/hcg086 · DOI
  73. 10.1093/eurheartj/ehi443 · DOI · Paper page
  74. 10.1210/jc.81.3.1018 · doi:10.1210/jc.81.3.1018 · Paper page
  75. 10.1007/s11892-003-0059-0 · DOI
  76. 10.1016/j.tips.2007.04.004 · DOI
  77. 10.1006/jmcc.1998.0844 · DOI · Paper page
  78. Montagnana M., 2008, Relationship between serum testosterone and cardiovascular risk profile in the general population, Arch Intern Med, 23, 168
  79. 10.1210/en.2007-1288 · DOI
  80. 10.1210/jc.2004-1158 · DOI · Paper page
  81. 10.1161/01.CIR.0000125854.51637.06 · DOI · Paper page
  82. Murphy JG, 1999, Decreased [Ca(2+)](i) during inhibition of coronary smooth muscle contraction by 17beta‐estradiol, progesterone, and testosterone, J Pharmacol Exp Ther, 291, 44, 10.1016/S0022-3565(24)35069-4 · DOI
  83. 10.1016/0021-9150(81)90070-8 · DOI
  84. 10.1016/j.lfs.2008.08.009 · DOI
  85. 10.1016/S1098-3597(08)80003-8 · DOI
  86. 10.1210/jc.2004-1611 · DOI
  87. 10.1016/j.lfs.2007.07.024 · DOI
  88. 10.1095/biolreprod.104.036954 · DOI
  89. 10.1161/01.ATV.14.5.701 · DOI · Paper page
  90. 10.1210/jc.2004-2190 · DOI · Paper page
  91. 10.1373/clinchem.2008.104901 · DOI · Paper page
  92. 10.7326/0003-4819-118-6-199303150-00006 · DOI · Paper page
  93. Prehn RT, 1999, On the prevention and therapy of prostate cancer by androgen administration, Cancer Res, 59, 4161
  94. 10.1016/S0195-668X(03)00083-6 · DOI · Paper page
  95. 10.1093/jnci/djm323 · DOI · Paper page
  96. 10.1046/j.1365-2265.2003.01796.x · DOI
  97. 10.1046/j.1365-2265.2001.01176.x · DOI
  98. 10.1016/j.ceca.2006.11.003 · DOI
  99. 10.1016/j.bbrc.2004.04.054 · DOI · Paper page
  100. 10.1254/jphs.FP0060883 · DOI
  101. 10.1210/jc.2007-2595 · DOI · Paper page
  102. 10.1001/archinte.166.15.1660 · DOI · Paper page
  103. Shores MM, Low serum testosterone and mortality in male veterans, Arch Int Med, 166, 1660, 10.1001/archinte.166.15.1660 · DOI · Paper page
  104. 10.1016/j.steroids.2004.05.009 · DOI · Paper page
  105. 10.1161/CIRCULATIONAHA.104.489088 · DOI · Paper page
  106. 10.1097/MED.0b013e32814db88c · DOI
  107. 10.1158/1078-0432.CCR-06-2086 · DOI
  108. 10.1007/s11934-008-0035-y · DOI
  109. 10.1210/jcem.86.9.7851 · DOI · Paper page
  110. 10.1016/S0002-9149(99)00357-4 · DOI
  111. Sochorová R., 1991, The possible influence of testosterone on calcium ion transport (investigated) in guinea pig uterus, Acta Physiol Hung, 77, 19
  112. 10.1002/ijc.11572 · DOI · Paper page
  113. 10.1038/sj.ijir.3901499 · DOI
  114. 10.1530/eje.0.1500065 · DOI · Paper page
  115. 10.1080/713604792 · DOI
  116. 10.1046/j.1365-2265.1998.00372.x · DOI
  117. 10.1016/S0014-2999(03)01453-5 · DOI
  118. 10.1001/jama.1989.03420080085036 · DOI · Paper page
  119. 10.2337/dc07-1231 · DOI · Paper page
  120. 10.2174/138161208786898699 · DOI
  121. 10.2164/jandrol.108.005215 · DOI · Paper page
  122. 10.1002/ijc.22814 · DOI
  123. 10.1016/S0021-9150(02)00308-8 · DOI
  124. 10.1016/j.amjcard.2007.09.114 · DOI
  125. 10.1016/S0002-9149(98)00880-7 · DOI · Paper page
  126. 10.1210/er.2001-0025 · DOI · Paper page
  127. 10.1016/j.juro.2006.03.057 · DOI
  128. 10.1055/s-2007-949657 · doi:10.1055/s-2007-949657
  129. 10.1097/01.fjc.0000161400.06704.1e · DOI
  130. 10.1161/01.CIR.91.4.1154 · DOI · Paper page
  131. 10.2174/187152906776092659 · DOI · Paper page
  132. 10.1016/0021-9150(95)05673-4 · DOI · Paper page
  133. 10.1093/oxfordjournals.aje.a009326 · DOI · Paper page

Cited by

See all 239

Metadata

Authors
Traish, A. M., Saad, F., Feeley, R. J., & Guay, A.
Venue
Journal of Andrology
Publisher
Wiley
Published
2009-09-10
Volume
30
Issue
5
Pages
477-494
ISSN
  • 0196-3635 (ISSN-L)
  • 1939-4640
OpenAlex
W2053748857
Cited by
239
References
39
FWCI
19.35
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease. https://app.cochat.ai/papers/10.2164/jandrol.108.007245
The paper
Traish, A. M., Saad, F., Feeley, R. J., & Guay, A. (2009). The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease. Journal of Andrology. https://doi.org/10.2164/jandrol.108.007245

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.